Matthew S. Davids, MD, MMSc
Chief, Division of Lymphoma
Harold and Virginia Lash Endowed Chair in Lymphoma Research
Dana-Farber Cancer Institute
Leader, Lymphoma Program, Harvard Cancer Consortium
Associate Professor of Medicine, Harvard Medical School
Boston, MA
Dr. Davids is an Associate Professor of Medicine at Harvard Medical School and Chief of the Division of Lymphoma at Dana-Farber Cancer Institute, as well as the Harold and Virginia Lash Endowed Chair in Lymphoma Research and the Leader of the Lymphoma Program of the Harvard Cancer Consortium. In addition to maintaining a busy clinical practice focused mainly on chronic lymphocytic leukemia (CLL), Dr. Davids leads numerous clinical trials of novel regimens for patients with CLL and lymphoma. He also runs a translational laboratory that utilizes functional precision medicine techniques to study patient samples, with goals of developing novel combination regimens, predicting response to therapy, and understanding resistance mechanisms to targeted agents.
